Home / Insights / Supply Chain Resilience: Diversifying Your API Intermediate Base
2026-06-22

Supply Chain Resilience: Diversifying Your API Intermediate Base

Lessons from post-pandemic supply shocks — why western pharma is again qualifying dual-source partners for critical API intermediates, and how Xi'an Greday Biological Technology supports that strategy.

The Geopolitical Reality

2024–2026 trade tensions, US Section 301 tariffs and EU CBAM carbon border taxes have accelerated a structural shift: western pharma is no longer comfortable with single-source exposure for late-pipeline API intermediates.

What “Dual-Sourcing” Actually Requires

  • A qualified second supplier (not just a quotation) with GMP documentation on file.
  • Technology transfer completed for at least one late-stage intermediate, with a 6-month performance run under cGMP.
  • A joint supply agreement covering allocation, pricing caps and force majeure clauses.

Xi’an Greday Biological Technology as Your Qualified Alternative

We have already completed technology transfer and qualification runs for 14 high-priority API intermediates with pharma partners in the US and EU. Our EU REACH registration and compliance with CBAM reporting requirements remove two common friction points for Western buyers.

Welcome to contact us to discuss API supply and contract manufacturing cooperation.

More Insights

2026-09-20

New Injectable API Product Lines — Indocyanine Green, Lidocaine and More — Expanding Our Export Portfolio

The company has completed a strategic expansion of its product portfolio, officially adding clinically essential injectable-grade APIs including Indocyanine Green for Injection, Lidocaine Hydrochloride and Gentamicin Sulfate, while completing formulation OEM contract-manufacturing registration documentation. Backed by mature end-to-end capabilities in export customs declaration, commodity inspection and customs clearance, we offer overseas customers a one-stop service of API supply + formulation contract manufacturing + registration dossier support, meeting hospital pharmacy and pharma mass-production needs across multiple countries.
2026-09-18

Green Chemistry & Sustainable Manufacturing at Xi'an Greday Biological Technology

How Xi'an Greday Biological Technology is investing in continuous-flow reactors, solvent recovery systems and renewable energy to cut environmental impact while maintaining the highest API intermediate quality.

2026-09-18

Tirzepatide and Orforglipron

"Xi'an Greday Biological Technology has completed small-scale synthesis and purity calibration of Tirzepatide and Orforglipron APIs, and can supply API powder, formulation development support and pilot-scale contract manufacturing, entering the GLP-1 innovative API market."